CA933864A - Suppositories - Google Patents

Suppositories

Info

Publication number
CA933864A
CA933864A CA094710A CA94710A CA933864A CA 933864 A CA933864 A CA 933864A CA 094710 A CA094710 A CA 094710A CA 94710 A CA94710 A CA 94710A CA 933864 A CA933864 A CA 933864A
Authority
CA
Canada
Prior art keywords
suppositories
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA094710A
Other languages
English (en)
Other versions
CA94710S (en
Inventor
J. Allen Donald
V. Bondi Joseph
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA933864A publication Critical patent/CA933864A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA094710A 1970-06-09 1970-10-02 Suppositories Expired CA933864A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4487670A 1970-06-09 1970-06-09

Publications (1)

Publication Number Publication Date
CA933864A true CA933864A (en) 1973-09-18

Family

ID=21934811

Family Applications (1)

Application Number Title Priority Date Filing Date
CA094710A Expired CA933864A (en) 1970-06-09 1970-10-02 Suppositories

Country Status (16)

Country Link
US (1) US3644630A (enExample)
AT (1) AT297936B (enExample)
BE (1) BE756975A (enExample)
CA (1) CA933864A (enExample)
CY (1) CY760A (enExample)
DK (1) DK125306B (enExample)
FI (1) FI50832C (enExample)
FR (1) FR2094129B1 (enExample)
GB (1) GB1284192A (enExample)
IE (1) IE34730B1 (enExample)
IL (1) IL35383A (enExample)
MY (1) MY7400233A (enExample)
NL (1) NL144482B (enExample)
NO (1) NO132614C (enExample)
SE (1) SE353657B (enExample)
ZA (1) ZA706715B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform
FR2500302B1 (fr) * 1981-02-25 1985-11-15 Negma Laboratoires Nouvelles compositions pharmaceutiques d'indometacine
GB2272654B (en) * 1992-11-02 1996-12-18 Minnesota Mining & Mfg Antistatic coatings
RU2169001C2 (ru) * 1998-03-03 2001-06-20 Щербак Игорь Федорович Способ получения гомеопатического суппозитория
RU2137468C1 (ru) * 1998-06-04 1999-09-20 ОАО "Нижегородский химико-фармацевтический завод" Суппозитории ректальные "апроксид"
RU2143261C1 (ru) * 1999-03-24 1999-12-27 Открытое акционерное общество "Московская фармацевтическая фабрика" Суппозитории, обладающие слабительным действием
US20240024284A1 (en) * 2022-07-20 2024-01-25 Fulton Medicinali S.P.A. Indomethacin pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL44885C (enExample) * 1935-11-09
US3163576A (en) * 1961-06-12 1964-12-29 Olin Mathieson Suppository base comprising glycerin and a diester of polyethylene glycol
US3669987A (en) * 1967-04-11 1972-06-13 Sumitomo Chemical Co Salts of indole derivatives and a process for preparing the same

Also Published As

Publication number Publication date
ZA706715B (en) 1972-05-31
IL35383A (en) 1974-07-31
MY7400233A (en) 1974-12-31
FR2094129A1 (enExample) 1972-02-04
BE756975A (fr) 1971-04-02
IL35383A0 (en) 1970-12-24
DE2049112A1 (de) 1971-12-16
FI50832C (fi) 1976-08-10
DK125306B (da) 1973-02-05
NL144482B (nl) 1975-01-15
NO132614C (enExample) 1975-12-10
FI50832B (enExample) 1976-04-30
SE353657B (enExample) 1973-02-12
AT297936B (de) 1972-04-10
FR2094129B1 (enExample) 1974-08-23
IE34730B1 (en) 1975-08-06
US3644630A (en) 1972-02-22
GB1284192A (en) 1972-08-02
IE34730L (en) 1971-12-09
NO132614B (enExample) 1975-09-01
CY760A (en) 1974-10-05
NL7014320A (enExample) 1971-12-13

Similar Documents

Publication Publication Date Title
AU472440B2 (en) 2-aminomethyl-4-6-dihalophenuls
CA965423A (en) Azepine-derivatives
CA941379A (en) 3-aryl-8-carbamoylnortropanes
CA943355A (en) Fascines
ZA706715B (en) Suppositories
CA948682A (en) All-terrain-vehicle
CA952613A (en) Commutateur temporel
AU417637B2 (en) Keyer-synthesizer
AU452351B2 (en) 18-METHYL-17a-ETHINYL-TESTOSTERON-ESTER
AU446442B2 (en) Imidazolribosylcyclophosphate
AU1278170A (en) Hydro-propeller
CA832421A (en) Suppository
CA858335A (en) Tab-opening can
CA831537A (en) Technique
CA850025A (en) Photoelectro-polymerization
CA836937A (en) Scraper-loader
CA838378A (en) Bratticing
CA849922A (en) Hatbox
CA846834A (en) Des-a-steroids
CA854202A (en) Thiocarbamyl-alkyl-amino-s-triazines
CA851199A (en) Phenylalkyl- and phenylcyclopropylsulfamides
CA859755A (en) N-4-aryl-1-piperazinylalkyl-5-aryloxazolidinones
CA876827A (en) Accompagnateur
CA833525A (en) Manganiding
CA832494A (en) Phenoxy-alkylamines